Search

everythinglearnresearchcommunity

for

Search:↓

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Best hair growth results from combining finasteride and minoxidil.

Finasteride works better than Serenoa repens for male hair loss.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Smoking increases early hair loss risk in men; quitting may help prevent it.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

SVF-PRP therapy effectively reverses hair loss effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

LLLT is a safe, promising hair loss treatment, but more research needed.

Low vitamin D levels are linked to increased risk of male pattern baldness.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

No link found between hair loss severity and PSA levels in men.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Altered hormones and insulin resistance are common in young men with early hair loss and linked to more severe cases.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Smoking may worsen hair loss, but more research is needed.

People with androgenetic alopecia have a higher risk of heart disease.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.